Document Detail

Bone marrow necrosis in two patients with acute promyelocytic leukemia during treatment with all-trans retinoic acid.
MedLine Citation:
PMID:  8042616     Owner:  NLM     Status:  MEDLINE    
All-trans retinoic acid has been used for the treatment of acute promyelocytic leukemia (APL) with encouraging results. However, it has recently been associated with a number of potentially serious complications including the retinoic acid syndrome. We describe two patients with APL who were begun on all-trans retinoic acid therapy (45 mg/m2), but who developed leukocytosis which was treated with hydroxyurea. Both patients demonstrated clinical and laboratory findings of disseminated intravascular coagulation, massive cell lysis manifested by marked increases in serum lactic dehydrogenase, and rapid clinical deterioration. Both patients developed bone marrow necrosis within viable, noninfarcted bone trabeculae. We postulate that the development of bone marrow necrosis in these two patients was not a chance occurrence. Rather, the specific combination of cytotoxic and differentiating agents used in these patients (hydroxyurea with all-trans retinoic acid) caused massive cell lysis and death. The absence of bone marrow necrosis in the setting of induction therapy for APL both with and without all-trans retinoic acid therapy suggests that the addition of hydroxyurea was critical to the development of marrow necrosis. We, therefore, recommend caution in the use of hydroxyurea and all-trans retinoic acid in the treatment of APL.
S A Limentani; J O Pretell; D Potter; J S DuBois; P R Daoust; P S Spieler; K B Miller
Related Documents :
9516856 - Retinoids in neuroblastoma therapy: distinct biological properties of 9-cis- and all-tr...
8670186 - Inhibition of proliferation of chondrocytes by specific receptors in response to retino...
15793506 - The effect of topical tretinoin on tissue strength and skin components in a murine inci...
11953746 - Genetic evidence that oxidative derivatives of retinoic acid are not involved in retino...
6373076 - Glucose in the dialyzate does not reduce the free amino acid loss during routine hemodi...
24415496 - Folin-ciocalteu spectrophotometric assay of ascorbic acid in pharmaceutical tablets and...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  American journal of hematology     Volume:  47     ISSN:  0361-8609     ISO Abbreviation:  Am. J. Hematol.     Publication Date:  1994 Sep 
Date Detail:
Created Date:  1994-08-19     Completed Date:  1994-08-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7610369     Medline TA:  Am J Hematol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  50-5     Citation Subset:  IM    
Department of Medicine, New England Medical Center, Boston, Massachusetts 02111.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bone Marrow / pathology*
Leukemia, Promyelocytic, Acute / complications,  drug therapy*
Necrosis / chemically induced,  etiology
Tretinoin / adverse effects,  therapeutic use*
Reg. No./Substance:
Comment In:
Am J Hematol. 1995 Jul;49(3):257-8   [PMID:  7604824 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Polyethylene glycolated interleukin-2 as maintenance therapy for acute myelogenous leukemia in secon...
Next Document:  Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or ant...